See also this year's filing and all EDGAR filings for this company.
PDF Report 0001645469_2026_Monopar_Therapeutics.pdf
Logs
Graph
Absolute values for 0001645469, Monopar Therapeutics
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 140,462,788 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 254,921 |
| 4 | LiabilitiesCurrent | 2,735,236 |
| 5 | LiabilitiesNoncurrent | 154,920 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 8,725,668 |
| 9 | ResearchAndDevelopmentExpense | 10,847,473 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 90,339 |
| 12 | remainder_NetIncome | 2,226,691 |
| 13 | remainder_ComprehensiveNetIncome | 98,609 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 140,717,709 |
| 1 | Liabilities | 2,890,156 |
| 2 | Expenses | 19,573,141 |
| 3 | Revenues | 90,339 |
| 4 | StockholdersEquity | 137,827,553 |
| 5 | NetIncome | -17,256,111 |
| 6 | ComprehensiveNetIncome | -17,206,806 |
| 7 | BaseVar | 82,798,322 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.94 |
| 9 | EconomicCapitalRatio | 4.35 |
Edgar->Model Mapping
Feature Distribution
Change over Time
